Brevan Howard Capital Management’s Transmedics TMDX Stock Holding History

Brevan Howard Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Buy	+28,808	New	+$2.44M	0.01%	735
2026 Q1	–	Sell	-7,761	Closed	-$944K	–	2491
2025 Q4	$944K	Sell	7,761 -9,719	-56%	-$1.22M	0.01%	799
2025 Q3	$1.96M	Buy	17,480 +7,129	+69%	+$835K	0.01%	571
2025 Q2	$1.39M	Buy	+10,351	New	+$1.14M	0.01%	912
2025 Q1	–	Sell	-10,114	Closed	-$631K	–	1458
2024 Q4	$631K	Buy	+10,114	New	+$941K	﹤0.01%	555

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Brevan Howard Capital Management's TMDX Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Transmedics (TMDX) in Q2 2026: 28,808 shares worth $1.91M. The stake represents 0.01% of the portfolio and ranks #735 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in TMDX as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in TMDX in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.96M in Q3 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Brevan Howard Capital Management held 28,808 shares of Transmedics worth $1.91M as of Q2 2026.
Transmedics was a new Brevan Howard Capital Management position in Q2 2026.
Transmedics made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #735 holding.
Brevan Howard Capital Management first reported a position in Transmedics in Q4 2024 and has held it in 5 quarters since.
Brevan Howard Capital Management's Transmedics position peaked at $1.96M in Q3 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.